Manufacturing & Lab Equipment
Company Overview
About
H&T Presspart is a pharmaceutical CDMO offering comprehensive services.
Key Expertise
Specialized in Biologics Manufacturing, Monoclonal Antibodies, Vaccines
Therapeutic Areas
Neurology
Quick Facts
HQ:Germany
Founded:2016
Employees:2,766
Capabilities & Services
Core Capabilities
- Cytotoxic / ADC Handling
- High-Potency API
- Sterile Fill/Finish
Types of Organization
GMP Manufacturing
Quality Systems
Regulatory Support
Dosage Forms
Topical / Transdermal
Containment Capabilities
BSL-2 (Biosafety Level 2)
Production Scales
Phase III Clinical Trials
Commercial Scale
Clinical
Markets Served
Europe
Regulatory Approvals
Drug Approval 5AXTTZ
PMDA · #APR-LKBDZRQ3 · 2019-12-01
Drug Approval B2P2KN
PMDA · #APR-MJRU25KZ · 2021-03-01
Certifications
FDA Registration
U.S. Food and Drug Administration
Cert #: CERT-VXHOH4NW
Issued: 2020-06-25
Expires: 2025-01-10
EMA GMP Certificate
European Medicines Agency
Cert #: CERT-GZM3PSEI
Issued: 2020-03-04
Expires: 2025-02-19
Loading CDMO intelligence...
Key facts about H&T Presspart
- H&T Presspart is headquartered in Germany.
- H&T Presspart was founded in 2016.
- H&T Presspart has 2,766 employees.
- H&T Presspart's capabilities include Cytotoxic / ADC Handling, High-Potency API and Sterile Fill/Finish.
Find CDMOs like H&T Presspart
Directory pages this company appears in, each with the full list of matching manufacturers.